COVID-19 Vaccines and Herd Immunity
JAMA Author Interviews · American Medical Association
December 21, 202048m 17s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020.
Related Article(s):
- COVID-19 Vaccines and Herd Immunity
- The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials
- Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines
- Herd Immunity and Implications for SARS-CoV-2 Control
- Herd Immunity as a Coronavirus Pandemic Strategy